⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Apotex Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Apotex Inc.
↗Toronto, Canada
Apotex Inc. is a Canadian-based global pharmaceutical corporation and the largest producer of generic drugs in Canada. Founded in 1974, the company develops, manufactures, and distributes a broad portfolio of generic pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs), and consumer health products, serving markets in over 115 countries.
Beyond its core generics business, Apotex has diversified into specialty pharmaceuticals, complex molecule development, and innovative medicines through its subsidiaries. The company is known for its aggressive approach to R&D and its unique litigation strategy in challenging brand-name drug patents to expand patient access to affordable medications.
CLASSIFICATION
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$2.5B+
Founded:1974
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biosimilars, Peptides
Active Trials:81
Trial Phases:-
FDA Approvals:230
CORPORATE STRUCTURE
Subsidiaries:ApoPharma, Apotex Pharmachem, Apotex Corp. (US)
Key Partnerships:Orbicular Pharmaceutical Technologies (Peptide development), Gland Pharma (Injectables)
COMPETITION
Position:Leader
Competitors:Teva Pharmaceutical Industries, Sandoz, Viatris, Amneal Pharmaceuticals
LEADERSHIP
Scientific Founders:Barry Sherman
LINKS
Website:apotex.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Apotex Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.